Mixed Results Show Underlying Strength

Cyient DLM's recent fourth-quarter results showed a mixed financial picture, with revenue and net profit declining year-on-year. However, a closer look reveals underlying strengths in its order book and alignment with growth trends in the electronics manufacturing services (EMS) sector. This suggests current performance might not fully capture its future potential.

Q4 FY26: Revenue Falls, Margins Squeeze

Cyient DLM reported consolidated revenue of ₹369.07 crore for the fourth quarter of fiscal year 2026, a 13.8% decrease year-on-year. This drop was partly due to a high comparative base from large prior-year orders and geopolitical disruptions in West Asia. The quarter-on-quarter revenue grew 21.7%. Net profit also fell year-on-year by 27.7% to ₹22.44 crore. EBITDA margins compressed by 170 basis points year-on-year to 11.6% due to operating deleverage. Despite these quarterly challenges, the stock reacted positively, rallying approximately 5.9% to ₹378.95 on April 22, 2026, suggesting investors focused on future prospects.

Order Book Hits Record High, Securing Future Growth

Despite the top-line pressures, Cyient DLM's order book reached a robust ₹24.17 billion at the close of the March quarter, its highest in eight quarters. This marks a significant year-on-year increase of 27%. With a book-to-bill ratio consistently above one across all quarters and strong order intake throughout fiscal year 2026, the company has substantial future revenue visibility. This backlog is critical as it buffers current revenue volatility and supports expectations for improved FY27 performance, driven by new client additions and a focus on high-margin orders.

Growth in Indian EMS Sector Positions Cyient DLM Well

The Indian EMS sector is growing rapidly, projected to reach $155 billion by 2030. This growth is fueled by government incentives like the PLI scheme and the global 'China +1' supply chain diversification strategy. Cyient DLM is strategically positioned, focusing on high-mix, low-to-medium volume, complex systems rather than just high-volume, low-margin production. While peers like Kaynes Technology and Syrma SGS Technology trade at higher P/E multiples (around 66x and 56x), Cyient DLM's lower P/E of approximately 31x to 40x suggests its stock could be valued higher if growth and margin targets are met. The company's expansion into medical, industrial, and aerospace segments targets higher-margin business opportunities.

Past Performance and Financial Prudence

This quarter's performance contrasts sharply with Cyient DLM's Q4 FY24 results, which saw revenue grow 18.3% year-on-year and net profit jump 36.5%. The current revenue contraction reflects the cyclical nature of large order completions and market dynamics. However, the company has shown financial prudence by significantly reducing total borrowings from ₹2,437.56 million in March 2025 to ₹1,061.25 million in March 2026. While its return on equity (ROE) of around 7-8% is lower than peers like Hind Rectifiers or Shanthi Gears, the growing order book provides a path to improve operational efficiency and capital returns.

Potential Risks and Challenges

Despite the positive order book and sector tailwinds, several risks warrant caution. The persistent year-on-year revenue decline for FY26 and Q4 FY26 is a primary concern, suggesting challenges in converting the strong backlog into realized sales efficiently. The company's reliance on large, specific orders, like those from BEL and in the defense segment, introduces revenue variability. While margins are expected to stabilize at Q4 levels for FY27, the operating deleverage seen in Q4 FY26 highlights how sensitive profitability is to revenue fluctuations. Geopolitical tensions in West Asia remain a risk for operations and supply chains. Competitors are increasingly focusing on higher-margin product mixes, pressuring Cyient DLM to differentiate its capabilities. The EBIT to interest coverage ratio of 2.69 times provides a limited buffer for debt payments if earnings fall.

Analyst Outlook and Stock Valuation

Analysts project a compound annual growth rate (CAGR) for Cyient DLM in revenue, EBITDA, and adjusted PAT ranging from 10.6% to 61% between FY25 and FY28. Motilal Oswal reiterates a BUY rating with a target price of ₹470, valuing the stock at 25 times its estimated FY28 earnings per share. This forward P/E multiple is attractive compared to its current trailing P/E ratios, which hover between 30x and 40x, and also relative to some higher-flying EMS peers. The company's guidance for improved FY27 performance, supported by new client wins and an expanding order book, suggests confidence in overcoming current revenue challenges and achieving margin stability. The average analyst target price of ₹469.67 reinforces a generally positive outlook, anticipating significant upside potential.